Infant pro-B acute lymphoblastic leukemia (B-ALL) harboring the fusion MLL-AF4 (MA4) represents a rare leukemia, associated with very brief latency and dismal prognosis, raising the question of how this disease evolves so quickly [2]. Here, KMT2A is linked to acute lymphoblastic leukemia.